BioCorRx Inc.
BICX
$0.478
$0.09825.79%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.75% | 21.70% | -22.19% | 1.58% | -27.70% |
| Total Depreciation and Amortization | 53.78% | 39.75% | -30.90% | -30.03% | -61.68% |
| Total Amortization of Deferred Charges | -25.50% | 1.78% | -39.77% | 23.85% | 29.75% |
| Total Other Non-Cash Items | -5.79% | -55.34% | 615.49% | -51.27% | 422.22% |
| Change in Net Operating Assets | -193.10% | 76.87% | -64.60% | 56.31% | 347.53% |
| Cash from Operations | -178.96% | 30.85% | -135.35% | 55.28% | 36.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 87.59% | -5.88% | 502.69% | -84.17% | -12.17% |
| Total Debt Repaid | -208.33% | 74.47% | -2,250.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.72% | -4.07% | 490.03% | -84.23% | -15.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.70% | 1,159.04% | 91.05% | -358.22% | 139.36% |